Discussion on judgments regarding amendments going beyond scope in European patent lawXUE Ya-ping, YIN Li-hua, LAO Jin-hua, LIN Tao-xi2801-2807
Compensation responsibility in the drug phase Ⅰ clinical trial safeguard system: enlightenment from Japan's relevant regulations and contents to ChinaMA Da-li, DENG Rui2808-2813
Consideration for preservative usage in multi-dose insulin formulationsZHAO Jing, BAI Yu, LUO Jian-hui, CHENG Su-yuan2814-2817
The development of new drugs for wet age-related macular degenerationXU Huan, GE Lin, ZHOU Mei-ling, KUANG Ye, HE Li, WANG Zhi-ming2818-2824
Research progress of lacosamide for the treatment of focal-onset seizures in patients with epilepsyMIAO Jie, SUN Mei-zhen2825-2831
Strategies for determination of genotoxic impurities in pharmaceuticalsWANG Sheng, HANG Tai-jun2840-2846
Progress in application of lyotropic liquid crystal in controlled release of drugWEN Jing, LI Tian-yang, HOU Wen-juan, ZHANG Yao-dong, GUO Rui-jie2847-2851
Efficacy and safety of phased-down oxycodone analgesia regimen for postoperative analgesia after abdominal surgeryZHANG Yun-xiao, TAN Hong-yu, DONG Chang-jiang, FAN Zhi-yi2852-2856
Clinical observation of setastine combined with tripterygium glycosides tablet for the treatment of chronic urticariaXIAO Chun-cai, ZHANG Chen-yang2857-2859